Ben Haim Menahem, Zwas S T, Munz Yaron, Rosin Dan, Shabtai Esther L, Kuriansky Joseph, Olchovsky David, Zmora Oded, Scarlat Alexander, Ayalon Amram, Shabtai Moshe
Department of Surgery, Endocrine Surgery Service, Sheba Medical Center, Tel Hashomer, Israel.
Isr Med Assoc J. 2003 May;5(5):326-8.
Primary hyperparathyroidism in elderly patients is usually associated with additional co-morbidity that increases operative risk, and thus many geriatric patients are denied the benefit of surgery for a single parathyroid adenoma.
To evaluate the safety and efficacy of accurate single photon emission computed tomography sestamibi scintigraphy, enabling precise localization of a single adenoma, in the geriatric population.
Twenty-two patients aged 70 years and over with biochemically proven PHPT and with a single parathyroid adenoma identified by localization studies (sestamibi SPECT scan and ultrasonography) underwent 23 operations over 29 months (out of a total of 140 patients operated upon during the same period). Immediate preoperative sestamibi scintigraphy and marking of focal adenoma uptake followed by intraoperative hand-held gamma probe were used for the removal of the parathyroid adenoma by unilateral minimal access surgery. Associated major co-morbid conditions and pre- and postoperative calcium, phosphorus and parathormone levels were recorded. Indications for surgery were listed and operative and postoperative complications were noted. The patients were followed for a mean period of 17.7 months using the same parameters.
The 22 patients with PHPT had a mean age of 76.3 +/- 5.9 years (range 70-88 years) and a female to male ratio of 13:9. Associated co-morbidity included ischemic heart disease (n = 15), hypertension (n = 22), non-insulin-dependent diabetes mellitus (n = 9), chronic obstructive pulmonary disease (n = 3), and previous neck surgery (n = 3). Mean preoperative serum calcium, phosphorous and PTH were 11.7 +/- 1.3 mg/dl, 2.5 +/- 0.5 mg/dl and 160.9 +/- 75.4 pg/ml respectively. In 20 of the 22 patients, surgery was successful in curing PHPT (91%). One patient had persistent hypercalcemia due to a missed adenoma, and repeat operation (by focused minimal accesss surgery) was successfully performed 2 weeks later. There were no complications and no morbidity postoperatively. Mean postoperative serum calcium, phosphorous and PTH were 9.6 +/- 1.2 mg/dl, 3.0 +/- 0.5 mg/dl and 35.2 +/- 24 pg/ml respectively. In all patients, serum calcium levels remained normal (9.7 +/- 1.3 mg/ml) after long-term follow-up (mean 17.7 +/- 9.6 months).
Minimally invasive, radio-guided focused parathyroidectomy for a single adenoma is a safe and effective method to cure hyperparathyroidism in the elderly. Success of surgery is directly related to the surgeon's experience and to the precise localization marking provided by sestamibi scintigraphic SPECT localization and concurrent sonographic findings.
老年患者的原发性甲状旁腺功能亢进通常与其他合并症相关,这会增加手术风险,因此许多老年患者无法从单个甲状旁腺腺瘤的手术中获益。
评估准确的单光子发射计算机断层扫描(SPECT) sestamibi闪烁扫描在老年人群中精确定位单个腺瘤的安全性和有效性。
22例年龄在70岁及以上、经生化检查证实为原发性甲状旁腺功能亢进且经定位研究(sestamibi SPECT扫描和超声检查)确定为单个甲状旁腺腺瘤的患者,在29个月内接受了23次手术(同期共140例患者接受手术)。术前即刻进行sestamibi闪烁扫描并标记腺瘤的局灶性摄取,随后术中使用手持式γ探头,通过单侧微创外科手术切除甲状旁腺腺瘤。记录相关的主要合并症以及术前、术后的钙、磷和甲状旁腺激素水平。列出手术指征,并记录手术及术后并发症。使用相同参数对患者进行平均17.7个月的随访。
22例原发性甲状旁腺功能亢进患者的平均年龄为76.3±5.9岁(范围70 - 88岁),女性与男性比例为13:9。相关合并症包括缺血性心脏病(n = 15)、高血压(n = 22)、非胰岛素依赖型糖尿病(n = 9)、慢性阻塞性肺疾病(n = 3)以及既往颈部手术史(n = 3)。术前血清钙、磷和甲状旁腺激素的平均水平分别为11.7±1.3mg/dl、2.5±0.5mg/dl和160.9±75.4pg/ml。22例患者中有20例手术成功治愈原发性甲状旁腺功能亢进(91%)。1例患者因腺瘤遗漏导致持续性高钙血症,2周后成功进行了再次手术(通过聚焦微创外科手术)。术后无并发症及不良事件。术后血清钙、磷和甲状旁腺激素的平均水平分别为9.6±1.2mg/dl、3.0±0.5mg/dl和35.2±24pg/ml。所有患者在长期随访(平均17.7±9.6个月)后血清钙水平保持正常(9.7±1.3mg/ml)。
对于单个腺瘤,微创、放射性引导的聚焦甲状旁腺切除术是治疗老年患者甲状旁腺功能亢进的一种安全有效的方法。手术的成功直接与外科医生的经验以及sestamibi闪烁扫描SPECT定位和同期超声检查结果提供的精确定位标记相关。